1. Title: Somatostatin, Alzheimer's disease and cognition: An old story coming of age? Author(s): Epelbaum
    Jacques; Guillou Jean-Louis; Gastambide Francois; et al. Source: PROGRESS IN NEUROBIOLOGY
    Volume: 89 Issue: 2 Pages: 153-161 DOI: 10.1016/j.pneurobio.2009.07.002 Published: OCT 2009 Times
    Cited: 7 (from All Databases) [ View abstract ] [ Hide abstract ]
  2. Title: Role of the somatostatin system in contextual fear memory and hippocampal synaptic plasticity Author
    (s): Kluge Christian; Stoppel Christian; Szinyei Csaba; et al. Source: LEARNING & MEMORY Volume: 15
    Issue: 4 Pages: 252-260 DOI: 10.1101/lm.793008 Published: APR 2008 Times Cited: 5 (from All
    Databases) [ View abstract ] [ Hide abstract ]  
  3. Title: Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in
    neuroendocrine tumors Author(s): Florio Tullio Source: FRONTIERS IN BIOSCIENCE Volume: 13 Pages:
    822-840 DOI: 10.2741/2722 Published: JAN 1 2008 Times Cited: 30 (from All Databases) [ View abstract ] [
    Hide abstract ]  
  4. Title: Cyclic insulin-regulated aminopeptidase (IRAP)/AT(4) receptor ligands Author(s): Axen Andreas;
    Lindeberg Gunnar; Demaegdt Heidi; et al. Source: JOURNAL OF PEPTIDE SCIENCE Volume: 12 Issue: 11
    Pages: 705-713 DOI: 10.1002/psc.782 Published: NOV 2006
  5. Chai SY, Fernando R, Peck G, et al. The angiotensin IV/AT(4) receptor CELL MOL LIFE SCI 61 (21): 2728-
    2737 NOV 2004
  6. Salam OMEA Modulation of inflammatory paw oedema by cysteamine in the rat PHARMACOL RES 45 (4):
    275-284 APR 2002
  7. Dutar P, Vaillend C, Viollet C, et al. Spatial learning and synaptic hippocampal plasticity in type 2
    somatostatin receptor knock-out mice NEUROSCIENCE 112 (2): 455-466 2002
  8. Falb E, Salitra Y, Yechezkel T, et al.A bicyclic and hsst2 selective somatostatin analogue: Design,
    synthesis, conformational analysis and binding BIOORGAN MED CHEM 9: (12) 3255-3264 DEC 2001
  9. Viollet C, Videau C, Epelbaum J Somatostatin and behaviour: The need for genetically engineered models J
    PHYSIOLOGY-PARIS 94: (3-4) 179-183 MAY-AUG 2000
  10. Petit A, Barelli H, Morain P, et al. Novel proline endopeptidase inhibitors do not modify A beta 40/42
    formation and degradation by human cells expressing wild-type and Swedish mutated beta-amyloid
    precursor protein BRIT J PHARMACOL 130: (7) 1613-1617 AUG 2000
  11. Martinez-Ferrer A, Boyano-Adanez MC, Izquieerdo-Claros RM, et al. Diazepam attenuation of somatostatin
    binding and effect of somatostatin on accumulation of inositol 1,4,5-trisphosphate in the rat frontoparietal
    cortex  NEUROPSYCHOPHARMACOL 23: (2) 178-187 AUG 2000
  12. Waters SM, Davis TP Alterations of peptide metabolism and neuropeptidase activity in senile dementia of
    the Alzheimer's type ANN NY ACAD SCI 814: 30-39 1997
  13. Guillou JL, Micheau J, Jaffard R Intrahippocampal injections of cysteamine improve the retention of a bar-
    pressing task in mice BEHAV BRAIN RES 103: (1) 113-117 AUG 1999
  14. Guillou JL, Micheau J, Jaffard R The opposite effects of cysteamine on the acquisition of two different tasks
    in mice are associated with bidirectional testing-induced changes in hippocampal adenylyl cyclase activity
    BEHAV NEUROSCI 112: (4) 900-908 AUG 1998
  15. Grimaldi M, Florio T, Schettini G Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes
    via the inhibition of adenylyl cyclase BIOCHEM BIOPH RES CO 235: (1) 242-248 JUN 9 1997
  16. Chevallier N, Jiracek J, Vincent B, et al.Examination of the role of endopeptidase 3.4.24.15 in A beta
    secretion by human transfected cells BRIT J PHARMACOL 121: (3) 556-562 JUN 1997
  17. DeVry J, Fritze J, Post RM The management of coexisting depression in patients with dementia: Potential of
    calcium channel antagonistsCLIN NEUROPHARMACOL 20: (1) 22-35 FEB 1997
  18. Tsunashima K Somatostatin update in CNS. JPN J NEUROPSYCHOPH 19: (2) 214-220 Sp. Iss. SI 1997
    DeVry J, Fritze J, Post RM The management of coexisting depression in patients with dementia: Potential of
    calcium channel antagonists CLIN NEUROPHARMACOL 20: (1) 22-35 FEB 1997
  19. Florio T, Thellung S, Schettini G Intracellular transducing mechanisms coupled to brain somatostatin
    receptors PHARMACOL RES 33: (6) 297-305 JUN 1996
  20. Florio T, Schettini G Multiple intracellular effectors modulate physiological functions of the cloned
    somatostatin receptors J MOL ENDOCRINOL 17: (2) 89-100 OCT 1996
  21. LopezFernandez J, SanchezFranco F, Velasco B, et al. Growth hormone induces somatostatin and insulin-
    like growth factor I gene expression in the cerebral hemispheres of aging rats ENDOCRINOLOGY 137: (10)
    4384-4391 OCT 1996
  22. Nakata A, Saito H, Nishiyama N Facilitatory role of somatostatin via muscarinic cholinergic system in the
    generation of long-term potentiation in the rat dentate gyrus in vivo BRAIN RES 723: (1-2) 135-140 JUN 3
    1996
  23. Dournaud P, JazatPoindessous F, Slama A, et al. Correlations between water maze performance and
    cortical somatostatin mRNA and high-affinity binding sites during ageing in rats EUR J NEUROSCI 8: (3)
    476-485 MAR 1996
  24. Roeske LC, Auchus AP Neuropeptide changes in cortical and deep gray structures in Alzheimer's Disease
    REV NEUROSCIENCE 6: (4) 317-328 OCT-DEC 1995
  25. Nakata A, Saito H, Nishiyama N Limited impairment of learning performances in mice treated with
    cysteamine BIOL PHARM BULL 18: (12) 1773-1775 DEC 1995
  26. REISINE T, BELL GI MOLECULAR-BIOLOGY OF SOMATOSTATIN RECEPTORS ENDOCR REV 16: (4)
    427-442 AUG 1995
  27. VECSEI L, KLIVENYI P SOMATOSTATIN AND ALZHEIMERS-DISEASE ARCH GERONTOL GERIAT 21: (1)
    35-41 JUL-AUG 1995
  28. SHIBATA S, TANAKA T, WATANABE S FACILITATORY EFFECTS OF SOMATOSTATIN ON REDUCED
    UPTAKE OF 2-DEOXYGLUCOSE IN CEREBRAL CORTICAL AND HIPPOCAMPAL SLICES FROM AGED
    RATS EUR J PHARM-MOLEC PH 269: (2) 269-272 OCT 14 1994
  29. MATSUOKA N, MAEDA N, YAMAGUCHI I, et al. POSSIBLE INVOLVEMENT OF BRAIN SOMATOSTATIN IN
    THE MEMORY FORMATION OF RATS AND THE COGNITIVE ENHANCING ACTION OF FR121196 IN
    PASSIVE-AVOIDANCE TASK BRAIN RES 642: (1-2) 11-19 APR 11 1994
  30. ICHAI C, CHEVALLIER N, DELAERE P, et al. INFLUENCE OF REGION-SPECIFIC ALTERATIONS OF
    NEUROPEPTIDASE CONTENT ON THE CATABOLIC FATES OF NEUROPEPTIDES IN ALZHEIMERS-
    DISEASE J NEUROCHEM 62: (2) 645-655 FEB 1994
  31. NILSSON L, MOHAMMED AKH, HENRIKSSON BG, et al. ENVIRONMENTAL INFLUENCE ON
    SOMATOSTATIN LEVELS AND GENE-EXPRESSION IN THE RAT-BRAIN BRAIN RES 628: (1-2) 93-98 NOV
    19 1993
  32. VECSEI L ALZHEIMERS-DISEASE AND SOMATOSTATIN - A THERAPEUTIC HYPOTHESIS BIOL PSYCHIAT
    34: (10) 673-675 NOV 15 1993
  33. THEVENIAU M, REISINE T DEVELOPMENTAL-CHANGES IN EXPRESSION OF A 60-KDA SOMATOSTATIN
    RECEPTOR IMMUNOREACTIVITY IN THE RAT-BRAIN J NEUROCHEM 60: (5) 1870-1875 MAY 1993
  34. LEROUX P, WEISSMANN D, PUJOL JF, et al. QUANTITATIVE AUTORADIOGRAPHY OF SOMATOSTATIN
    RECEPTORS IN THE RAT LIMBIC SYSTEM J COMP NEUROL 331: (3) 389-401 MAY 15 1993
  35. RAYNOR K, REISINE T SOMATOSTATIN RECEPTORS CRIT REV NEUROBIOL 6: (4) 273-289 1992
  36. KRANTIC S, ROBITAILLE Y, QUIRION R DEFICITS IN THE SOMATOSTATIN SS1 RECEPTOR SUB-TYPE IN
    FRONTAL AND TEMPORAL CORTICES IN ALZHEIMERS-DISEASE BRAIN RES 573: (2) 299-304 FEB 28
    1992
  37. MOURADIAN MM, BLIN J, GIUFFRA M, et al. SOMATOSTATIN REPLACEMENT THERAPY FOR ALZHEIMER
    DEMENTIA ANN NEUROL 30: (4) 610-613 OCT 1991
  38. FLORIO T, VENTRA C, POSTIGLIONE A, et al. AGE-RELATED ALTERATIONS OF SOMATOSTATIN GENE-
    EXPRESSION IN DIFFERENT RAT-BRAIN AREAS BRAIN RES 557: (1-2) 64-68 AUG 23 1991
  39. SCHETTINI G BRAIN SOMATOSTATIN - RECEPTOR-COUPLED TRANSDUCING MECHANISMS AND ROLE
    IN COGNITIVE FUNCTIONS PHARMACOL RES 23: (3) 203-215 APR 1991
  40. VECSEI L, WIDERLOV E PRECLINICAL AND CLINICAL-STUDIES WITH CYSTEAMINE AND PANTETHINE
    RELATED TO THE CENTRAL-NERVOUS-SYSTEM PROG NEURO-PSYCHOPH 14: (6) 835-862 1990
  41. KRANTIC S, MARTEL JC, WEISSMANN D, et al. QUANTITATIVE AUTORADIOGRAPHIC STUDY OF
    SOMATOSTATIN RECEPTORS HETEROGENEITY IN THE RAT EXTRAHYPOTHALAMIC BRAIN
    NEUROSCIENCE 39: (1) 127-137 1990
  42. BEAL MF SOMATOSTATIN IN NEURODEGENERATIVE ILLNESSES METABOLISM 39: (9) 116-119 Suppl. 2
    SEP 1990
  43. VECSEI L, ALLING C, WIDERLOV E COMPARATIVE-STUDIES OF INTRACEREBROVENTRICULARLY
    ADMINISTERED CYSTEAMINE AND PANTETHINE IN DIFFERENT BEHAVIORAL-TESTS AND ON BRAIN
    CATECHOLAMINES IN RATS ARCH INT PHARMACOD T 305: 140-151 MAY-JUN 1990
  44. MARINO A, FLORIO T, MEUCCI O, et al. FIPEXIDE IMPROVEMENT OF COGNITIVE FUNCTIONS IN RAT -
    BEHAVIORAL AND NEUROCHEMICAL STUDIES PHARMACOL RES 22: (2) 179-187 MAR-APR 1990
  45. SANCHEZFRANCO F, CACICEDO L, LORENZO MJ, et al. NEUROSECRETORY AND TROPHIC ACTION ON
    FETAL-RAT NEUROBLASTS INDUCED BY AN AMINO-ACID MIXTURE BIOCHEM MED METAB B 43: (1) 10-
    21 FEB 1990
  46. VECSEI L, PAVO I, ZSIGO J, et al. COMPARATIVE STUDIES OF SOMATOSTATIN-14 AND SOME OF ITS
    FRAGMENTS ON PASSIVE-AVOIDANCE BEHAVIOR, OPEN-FIELD ACTIVITY AND ON BARREL ROTATION
    PHENOMENON IN RATS PEPTIDES 10: (6) 1153-1157 NOV-DEC 1989
  47. FROSTL W, MAITRE L THE FAMILIES OF COGNITION ENHANCERS PHARMACOPSYCHIATRY 22: 54-100
    Suppl. 2 OCT 1989
  48. SCHETTINI G, FLORIO T, MEUCCI O, et al. SOMATOSTATIN INHIBITION OF ADENYLATE-CYCLASE
    ACTIVITY IN DIFFERENT BRAIN-AREAS BRAIN RES 492: (1-2) 65-71 JUL 17 1989
  49. VECSEI L, WIDERLOV E, EKMAN R, et al. CYSTEAMINE AND PANTETHINE EFFECTS ON PASSIVE-
    AVOIDANCE BEHAVIOR, SHUTTLE BOX LEARNING, OPEN-FIELD ACTIVITY, STRIATAL
    CATECHOLAMINES AND SOMATOSTATIN ARCH INT PHARMACOD T 299: 14-27 MAY-JUN 1989